Molecular CellMolecular BiologyPeer-reviewed journal article
FMRP phosphorylation modulates neuronal translation through YTHDF1
Zhongyu ZouiD, Jiangbo WeiiD, Yantao CheniD, Yunhee KangiD, Hailing ShiiD, Fan YangiD, Zhuoyue ShiiD, Shijie CheniD, Ying Zhou, Caraline Sepich‐PooreiD, Xiaoxi ZhuangiD, Xiaoming ZhouiD, Hualiang JiangiD, Zhexing WeniD, Peng JiniD, Cheng LuoiD, Chuan HeiD
Abstract
Translation activation of local synaptic mRNAs is critical to learning and memory1-3. Despite extensive studies on how phosphorylation of ribosomal proteins and translation factors enables timely response to exogenous stimuli4, our knowledge on molecular pathways utilized by RNA binding proteins (RBPs) to control translation of specific mRNAs remains incomplete. We have previously found that YTHDF1 regulates depolarization-induced protein synthesis by promoting translation of N6-methyladenosine (m6A)-modified transcripts5. Here we report an unexpected mechanism that the stimuli-induced neuronal translation is mediated by phosphorylation of a YTHDF1-binding protein FMRP. Phosphorylation of FMRP serine 499 induced by neuronal depolarization alters the condensing behavior of prion-like protein YTHDF1. Unphosphorylated FMRP sequesters YTHDF1 away from the translation initiation complex, whereas the stimulation-induced FMRP phosphorylation releases YTHDF1 to form translational active condensates with the ribosome to activate translation of YTHDF1 target transcripts. In fragile X syndrome (FXS) models characterized by low FMRP expression, we observed YTHDF1-mediated hyperactive translation, which notably impacts FXS pathophysiology. Developmental defects in an FXS forebrain organoid model could be reversed by a selective small-molecule inhibitor of YTHDF1 which acts by suppressing its condensation in neurons. We characterized transcriptome-wide mRNA translation with inhibitor treatment in organoids and identified targets that explain alleviated FXS pathology. Our study thus reveals FMRP and its phosphorylation as an important regulator of the activity-dependent translation during neuronal development and stimulation, and identifies YTHDF1 as a potential therapeutic target for FXS in which developmental defects caused by FMRP depletion could be reversed through YTHDF1 inhibition.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- research focus: protein structure prediction
- approach: experimental assay
- Citations
- 90
- FWCI
- 14.92
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- m⁶A-dependent FMRP control of DGKκ translation underlies core Fragile X phenotypes
Oktay Cakil, Boglárka Zámbó, … Hervé Moine·bioRxiv·Mar 10, 2026
- Function of FMRP domains in regulating distinct roles of neuronal protein synthesis
Michelle Ninochka D’Souza, Sarayu Ramakrishna, … Ravi Sondekoppa Muddashetty·Molecular NeurobiologyPeer-reviewed·Oct 1, 2022
- Phosphorylation alters FMRP granules and determines their transport or protein synthesis abilities
Shivani C. Kharod, Dong-Woo Hwang, … Young J. Yoon·bioRxiv·Mar 15, 2023
- Neuronal potassium channel activity triggers initiation of mRNA translation through binding of translation regulators
Taylor Joseph Malone, Jing Wu, … Leonard K. Kaczmarek·Science AdvancesPeer-reviewed·May 28, 2025
- Excess ribosomal protein production unbalances translation in Fragile X Syndrome
Sang S. Seo, Susana R. Louros, … Emily K. Osterweil·bioRxiv·Apr 7, 2022
- Opto-CLIP reveals dynamic FMRP regulation of mRNAs upon CA1 neuronal activation
Ruth A. Singer, Veronika Rajchin, … Robert B. Darnell·bioRxiv·Aug 13, 2024